首页> 美国卫生研究院文献>Molecular Cancer >Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression
【2h】

Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression

机译:短发夹RNA诱导的乳腺癌细胞中腺嘌呤核苷酸translocase-2的抑制通过激活JNK和调节TRAIL受体表达来恢复其对TRAIL诱导的凋亡的敏感性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL; apo2 ligand) induces apoptosis in cancer cells but has little effect on normal cells. However, many cancer cell types are resistant to TRAIL-induced apoptosis, limiting the clinical utility of TRAIL as an anti-cancer agent. We previously reported that the suppression of adenine nucleotide translocase-2 (ANT2) by short-hairpin RNA (shRNA) induces apoptosis of breast cancer cells, which frequently express high levels of ANT2. In the present study, we examined the effect of RNA shRNA-induced suppression of ANT2 on the resistance of breast cancer cells to TRAIL-induced apoptosis in vitro and in vivo.
机译:背景肿瘤坏死因子(TNF)相关凋亡诱导配体(TRAIL; apo2配体)诱导癌细胞凋亡,但对正常细胞影响很小。但是,许多癌细胞对TRAIL诱导的细胞凋亡具有抗性,限制了TRAIL作为抗癌剂的临床应用。我们以前曾报道过,短发夹RNA(shRNA)对腺嘌呤核苷酸translocase-2(ANT2)的抑制作用可诱导经常表达高水平ANT2的乳腺癌细胞凋亡。在本研究中,我们研究了RNA shRNA诱导的ANT2抑制在体外和体内对乳腺癌细胞对TRAIL诱导的凋亡的抗性的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号